交易 Marinus Pharmaceuticals, Inc. - MRNS CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
交易條件
| 价差 | 0.05 | ||||||||
|
多头隔夜费
多头隔夜费
前往平台 | -0.026179% | ||||||||
|
空头隔夜费
空头隔夜费
前往平台 | 0.003957% | ||||||||
| 隔夜费时间 | 21:00 (UTC) | ||||||||
| 最小交易量 | 1 | ||||||||
| 货币 | USD | ||||||||
| 保证金 | 5% | ||||||||
| 上市交易所 | United States of America | ||||||||
| 交易费 | 0% |
*Information provided by Capital.com
Marinus Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
| 日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
|---|---|---|---|---|---|---|
| Apr 18, 2024 | 1.38 | -0.05 | -3.50% | 1.43 | 1.50 | 1.14 |
| Apr 17, 2024 | 1.41 | 0.21 | 17.50% | 1.20 | 1.51 | 1.14 |
| Apr 16, 2024 | 1.15 | -0.18 | -13.53% | 1.33 | 1.62 | 1.09 |
| Apr 15, 2024 | 1.26 | -0.57 | -31.15% | 1.83 | 1.90 | 1.23 |
| Apr 12, 2024 | 7.48 | -0.35 | -4.47% | 7.83 | 7.96 | 7.40 |
| Apr 11, 2024 | 7.88 | -0.12 | -1.50% | 8.00 | 8.22 | 7.87 |
| Apr 10, 2024 | 8.05 | 0.20 | 2.55% | 7.85 | 8.21 | 7.84 |
| Apr 9, 2024 | 8.35 | 0.42 | 5.30% | 7.93 | 8.39 | 7.93 |
| Apr 8, 2024 | 8.15 | 0.36 | 4.62% | 7.79 | 8.22 | 7.38 |
| Apr 5, 2024 | 7.77 | -0.81 | -9.44% | 8.58 | 8.87 | 7.72 |
| Apr 4, 2024 | 8.64 | 0.20 | 2.37% | 8.44 | 8.91 | 8.44 |
| Apr 3, 2024 | 8.68 | 0.05 | 0.58% | 8.63 | 8.98 | 8.34 |
| Apr 2, 2024 | 8.83 | 0.14 | 1.61% | 8.69 | 8.92 | 8.63 |
| Apr 1, 2024 | 8.95 | 0.33 | 3.83% | 8.62 | 9.04 | 8.50 |
| Mar 28, 2024 | 8.98 | 0.13 | 1.47% | 8.85 | 9.21 | 8.77 |
| Mar 27, 2024 | 8.83 | 0.03 | 0.34% | 8.80 | 9.04 | 8.52 |
| Mar 26, 2024 | 8.74 | -0.31 | -3.43% | 9.05 | 9.33 | 8.44 |
| Mar 25, 2024 | 8.91 | 0.17 | 1.95% | 8.74 | 8.94 | 8.74 |
| Mar 22, 2024 | 8.79 | 0.01 | 0.11% | 8.78 | 9.03 | 8.61 |
| Mar 21, 2024 | 9.00 | 0.14 | 1.58% | 8.86 | 9.09 | 8.80 |
Marinus Pharmaceuticals, Inc. Events
| 时间（协调世界时） (UTC) | 国家 | 事件 |
|---|---|---|
| Thursday, May 9, 2024 | ||
| 时间（协调世界时） (UTC) 12:30 | 国家 US
| 事件 Q1 2024 Marinus Pharmaceuticals Inc Earnings Release Q1 2024 Marinus Pharmaceuticals Inc Earnings ReleaseForecast（预报） -上一页 - |
| Wednesday, May 22, 2024 | ||
| 时间（协调世界时） (UTC) 13:30 | 国家 US
| 事件 Marinus Pharmaceuticals Inc Annual Shareholders Meeting Marinus Pharmaceuticals Inc Annual Shareholders MeetingForecast（预报） -上一页 - |
| Thursday, May 23, 2024 | ||
| 时间（协调世界时） (UTC) 13:30 | 国家 US
| 事件 Marinus Pharmaceuticals Inc Annual Shareholders Meeting Marinus Pharmaceuticals Inc Annual Shareholders MeetingForecast（预报） -上一页 - |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 總收入 | 25.478 | 15.345 | 1.718 | 0 | 0 |
| 總營業費用 | 139.066 | 112.476 | 69.655 | 54.422 | 37.179 |
| 銷售/一般/行政費用，總計 | 56.845 | 37.278 | 18.549 | 11.456 | 8.785 |
| 研究與開發 | 79.912 | 73.52 | 51.106 | 42.966 | 28.394 |
| 營業收入 | -113.588 | -97.131 | -67.937 | -54.422 | -37.179 |
| 利息收入（費用），非經營淨值 | -8.318 | -2.502 | 0.499 | 0.354 | 0.454 |
| 其他，淨值 | -1.896 | 0.857 | -0.037 | -0.053 | -0.001 |
| 稅前淨收入 | -16.427 | -98.776 | -67.475 | -54.121 | -36.726 |
| 稅後淨收入 | -19.816 | -98.776 | -67.475 | -54.121 | -36.726 |
| 未計算非常項目前的淨收益 | -19.816 | -98.776 | -67.475 | -54.121 | -36.726 |
| 淨收入 | -19.816 | -98.776 | -67.475 | -54.121 | -36.726 |
| Total Adjustments to Net Income | 0 | -8.88 | |||
| 普通股股東可獲收益 (不含非經常性項目) | -19.816 | -98.776 | -76.355 | -54.121 | -36.726 |
| 普通股股東可獲收益 (含非經常性項目) | -19.816 | -98.776 | -76.355 | -54.121 | -36.726 |
| 攤薄淨收入 | -19.816 | -98.776 | -76.355 | -54.121 | -36.726 |
| 攤薄後加權平均股 | 39.0726 | 36.6972 | 27.2701 | 13.6282 | 10.2239 |
| 扣除特別項目的每股攤薄盈利 | -0.50716 | -2.69165 | -2.79996 | -3.97125 | -3.59219 |
| 每股正常攤薄盈利 | -2.28011 | -2.64593 | -2.79996 | -3.97125 | -3.59219 |
| 收入 | 25.478 | 15.345 | 1.718 | ||
| 異常費用（收入） | 0.8 | 1.678 | |||
| 收入成本，共計 | 1.509 | ||||
| 毛利 | 23.969 | ||||
| Gain (Loss) on Sale of Assets | 107.375 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| 總收入 | 6.081 | 10.38 | 7.162 | 2.34 | 15.976 |
| 收入 | 6.081 | 10.38 | 7.162 | 2.34 | 15.976 |
| 總營業費用 | 37.52 | 43.343 | 37.174 | 32.439 | 69.453 |
| 銷售/一般/行政費用，總計 | 15.722 | 15.204 | 14.658 | 13.389 | 28.798 |
| 研究與開發 | 21.412 | 27.933 | 21.424 | 19.002 | 39.486 |
| 營業收入 | -31.439 | -32.963 | -30.012 | -30.099 | -53.477 |
| 利息收入（費用），非經營淨值 | -2.08 | -1.804 | -1.946 | -2.12 | -4.252 |
| 其他，淨值 | 0.047 | 0.037 | -0.717 | -0.114 | -1.065 |
| 稅前淨收入 | -33.472 | -34.73 | -32.675 | 75.042 | -58.794 |
| 稅後淨收入 | -31.934 | -34.73 | -34.312 | 73.29 | -58.794 |
| 未計算非常項目前的淨收益 | -31.934 | -34.73 | -34.312 | 73.29 | -58.794 |
| 淨收入 | -31.934 | -34.73 | -34.312 | 73.29 | -58.794 |
| Total Adjustments to Net Income | 0.336 | -1.656 | 1.32 | ||
| 普通股股東可獲收益 (不含非經常性項目) | -31.934 | -34.73 | -33.976 | 71.634 | -57.474 |
| 普通股股東可獲收益 (含非經常性項目) | -31.934 | -34.73 | -33.976 | 71.634 | -57.474 |
| 攤薄淨收入 | -31.934 | -34.73 | -33.976 | 71.634 | -57.474 |
| 攤薄後加權平均股 | 52.5519 | 51.7697 | 45.0382 | 37.9105 | 37.1432 |
| 扣除特別項目的每股攤薄盈利 | -0.60767 | -0.67086 | -0.75438 | 1.88956 | -1.54736 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| 每股正常攤薄盈利 | -0.60767 | -0.67086 | -0.74284 | 0.04854 | -1.54736 |
| 異常費用（收入） | 0.8 | ||||
| 收入成本，共計 | 0.386 | 0.206 | 0.292 | 0.048 | 1.169 |
| 毛利 | 5.695 | 10.174 | 6.87 | 2.292 | 14.807 |
| Gain (Loss) on Sale of Assets | 0 | 107.375 | 0 |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 流動資産總額 | 252.378 | 131.678 | 146.267 | 94.134 | 73.94 |
| 現金和短期投資 | 240.551 | 122.927 | 139.983 | 91.682 | 72.725 |
| 現金等價物 | 240.551 | 122.927 | 138.509 | 90.943 | 67.727 |
| 短期投資 | 0 | 1.474 | 0.739 | 4.998 | |
| 預付的費用 | 5.402 | 5.565 | 4.638 | 2.452 | 1.215 |
| 總資産 | 259.518 | 136.84 | 150.462 | 98.842 | 75.234 |
| 物業/廠房/設備，總計 - 淨額 | 5.536 | 4.199 | 3.945 | 4.765 | 1.294 |
| 物業/廠房/設備，總計 - 總額 | 6.99 | 5.593 | 5.077 | 5.577 | 1.904 |
| 累計折舊，總計 | -1.454 | -1.394 | -1.132 | -0.812 | -0.61 |
| 長期投資 | 0 | ||||
| 其他長期資産，總計 | 1.604 | 0.963 | 0.25 | -0.057 | |
| 流動負債總額 | 25.017 | 40.566 | 10.729 | 8.031 | 6.909 |
| 應付賬款 | 4.461 | 3.126 | 2.211 | 2.763 | 2.472 |
| 預提費用 | 19.536 | 16.207 | 8.518 | 5.268 | 4.437 |
| 應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
| 長期債務的當前部分/資本租賃 | |||||
| 其他流動負債，總計 | 1.02 | 21.233 | |||
| 負債總額 | 143.518 | 83.354 | 13.263 | 11.073 | 6.909 |
| 長期債務總額 | 71.018 | 40.809 | 0 | 0 | 0 |
| 長期債務 | 71.018 | 40.809 | |||
| 其他負債，總計 | 47.483 | 1.979 | 2.534 | 3.042 | 0 |
| 總權益 | 116 | 53.486 | 137.199 | 87.769 | 68.325 |
| 普通股 | 0.05 | 0.037 | 0.037 | 0.087 | 0.053 |
| 額外實收資本 | 542.428 | 459.852 | 444.622 | 295.056 | 249.727 |
| 留存收益（累計赤字） | -430.521 | -410.705 | -311.929 | -235.574 | -181.453 |
| 總負債和股東權益 | 259.518 | 136.84 | 150.462 | 98.842 | 75.234 |
| 已發行普通股總數 | 49.6428 | 36.7902 | 36.5785 | 21.6178 | 13.1298 |
| 其他權益，總計 | 0 | -0.002 | |||
| Treasury Stock - Common | 0 | 0 | 0 | 0 | 0 |
| Redeemable Preferred Stock | 4.043 | 4.302 | 4.469 | 28.2 | |
| 應收賬款總額，淨額 | 6.348 | 3.186 | 1.646 | ||
| 應收賬款 - 貿易，淨額 | 6.348 | 3.186 | 1.646 | ||
| Total Preferred Shares Outstanding | 0.0043 | 0.00458 | 0.00475 | ||
| 總庫存 | 0.077 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| 流動資産總額 | 195.04 | 194.609 | 219.995 | 252.378 | 177.006 |
| 現金和短期投資 | 176.356 | 175.336 | 199.201 | 240.551 | 168.249 |
| 現金等價物 | 140.437 | 127.787 | 146.904 | 240.551 | 168.249 |
| 短期投資 | 35.919 | 47.549 | 52.297 | ||
| 應收賬款總額，淨額 | 4.281 | 5.234 | 11.693 | 6.348 | 3.398 |
| 應收賬款 - 貿易，淨額 | 4.281 | 5.234 | 11.693 | 6.348 | 3.398 |
| 預付的費用 | 11.667 | 11.365 | 9.064 | 5.402 | 5.255 |
| 總資産 | 200.806 | 201.2 | 226.817 | 259.518 | 184.841 |
| 物業/廠房/設備，總計 - 淨額 | 4.909 | 5.038 | 5.237 | 5.536 | 6.92 |
| 其他長期資産，總計 | 0.857 | 1.553 | 1.585 | 1.604 | 0.915 |
| 流動負債總額 | 30.555 | 25.603 | 21.514 | 25.017 | 21.05 |
| 應付賬款 | 2.626 | 2.302 | 4.466 | 4.461 | 1.622 |
| 預提費用 | 18.328 | 17.895 | 15.727 | 19.536 | 19.428 |
| 應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
| 負債總額 | 146.269 | 143.861 | 141.732 | 143.518 | 102.837 |
| 長期債務總額 | 64.783 | 68.136 | 71.498 | 71.018 | 70.78 |
| 其他負債，總計 | 50.931 | 50.122 | 48.72 | 47.483 | 11.007 |
| 總權益 | 54.537 | 57.339 | 85.085 | 116 | 82.004 |
| Redeemable Preferred Stock | 0 | 0 | 4.043 | 4.043 | 4.043 |
| 普通股 | 0.055 | 0.051 | 0.05 | 0.05 | 0.037 |
| 額外實收資本 | 584.71 | 554.587 | 546.169 | 542.428 | 474.133 |
| 留存收益（累計赤字） | -530.157 | -497.185 | -465.251 | -430.521 | -396.209 |
| 總負債和股東權益 | 200.806 | 201.2 | 226.817 | 259.518 | 184.841 |
| 已發行普通股總數 | 54.5735 | 50.6092 | 49.6651 | 49.6428 | 37.1966 |
| Total Preferred Shares Outstanding | 0 | 0 | 0.0043 | 0.0043 | 0.0043 |
| 長期債務 | 64.783 | 68.136 | 71.498 | 71.018 | 70.78 |
| Treasury Stock - Common | 0 | 0 | 0 | ||
| 其他流動負債，總計 | 1.901 | 1.556 | 1.321 | 1.02 | 0 |
| 總庫存 | 2.736 | 2.674 | 0.037 | 0.077 | 0.104 |
| 物業/廠房/設備，總計 - 總額 | 6.99 | ||||
| 累計折舊，總計 | -1.454 | ||||
| 其他權益，總計 | -0.071 | -0.114 | 0.074 | ||
| 長期債務的當前部分/資本租賃 | 7.7 | 3.85 |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 净收入/起跑线 | -19.816 | -98.776 | -67.475 | -54.121 | -36.726 |
| 经营活动产生的现金 | -112.886 | -55.477 | -60.912 | -48.633 | -27.842 |
| 经营活动产生的现金 | 0.418 | 0.355 | 0.334 | 0.278 | 0.127 |
| 非现金物品 | -87.396 | 14.245 | 8.271 | 5.8 | 4.709 |
| 已付现金利息 | 7.892 | 0 | |||
| 营运资金的变化 | -6.092 | 28.699 | -2.042 | -0.59 | 4.048 |
| 投资活动产生的现金 | 105.772 | -1.415 | -0.738 | 3.881 | 19.917 |
| 资本支出 | -1.774 | -2.889 | 0 | -0.388 | -0.083 |
| 其他投资现金流量项目，总计 | 107.546 | 1.474 | -0.738 | 4.269 | 20 |
| 融资活动产生的现金 | 124.738 | 41.31 | 109.216 | 67.968 | 42.121 |
| 融资现金流项目 | 29.879 | -0.148 | 42.3 | ||
| 股票的发行（报废），净额 | 66.271 | 1.199 | 109.216 | 67.968 | 0.014 |
| 债务的发行（退还），净额 | 28.588 | 40.259 | 0 | -0.193 | |
| 现金净变化 | 117.624 | -15.582 | 47.566 | 23.216 | 34.196 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -34.73 | -19.816 | 14.496 | -58.794 | -19.361 |
| Cash From Operating Activities | -41.478 | -112.886 | -90.972 | -61.327 | -27.655 |
| Cash From Operating Activities | 0.157 | 0.418 | 0.336 | 0.178 | 0.085 |
| Non-Cash Items | 5.231 | -87.396 | -93.437 | 9.791 | 5.594 |
| Changes in Working Capital | -12.136 | -6.092 | -12.367 | -12.502 | -13.973 |
| Cash From Investing Activities | -51.995 | 105.772 | 105.693 | -0.421 | -0.086 |
| Capital Expenditures | 0 | -1.774 | -1.682 | -0.421 | -0.086 |
| Other Investing Cash Flow Items, Total | -51.995 | 107.546 | 107.375 | 0 | |
| Cash From Financing Activities | -0.174 | 124.738 | 30.601 | 31.147 | 31.133 |
| Financing Cash Flow Items | -0.174 | 29.879 | 0 | ||
| Issuance (Retirement) of Stock, Net | 0 | 66.271 | 1.763 | 1.747 | 1.733 |
| Net Change in Cash | -93.647 | 117.624 | 45.322 | -30.601 | 3.392 |
| Issuance (Retirement) of Debt, Net | 0 | 28.588 | 28.838 | 29.4 | 29.4 |
差價合約交易計算器
如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模（槓桿 x 投資）：
打開
關閉
做空 做多
Marinus Pharmaceuticals, Inc. Company profile
关于 Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc是一家位于美国的生物制药公司。 该公司提供用于治疗严重的神经和精神疾病的医疗药物的开发和商业化，如癫痫、创伤后压力和脆弱-x综合症。 其临床阶段的候选产品Ganaxolone是一种调节剂，正在开发各种剂量形式，包括静脉注射、口服胶囊和口服液，旨在为急性和慢性护理中的成人和儿童患者群体提供更多的治疗选择。
| Industry: | Pharmaceuticals (NEC) |
Three Radnor Corporate Center
100 Matsonford Rd, Suite 304
RADNOR
PENNSYLVANIA 19087
US
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗？
加入成为全球610,000万多名交易者的一份子，选择利用Capital.com进行交易吧。